Talphera (TLPH) Cash from Investing Activities (2010 - 2026)
Talphera (TLPH) posted quarterly Cash from Investing Activities of -$2.7 million for Q1 2026, down 178.21% quarter-over-quarter from $3.5 million in Q4 2025.
Talphera (TLPH) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Talphera's Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$2.7 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities changed N/A year-over-year to -$2.7 million; the TTM figure through Mar 2026 stood at -$17.1 million (down 362.0% YoY), while the FY2025 annual figure was -$14.3 million, down 479.4% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$2.7 million, down from $3.5 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $20.2 million in Q1 2022, with the low at -$17.8 million in Q3 2025.
- The 5-year median for Cash from Investing Activities is $2.7 million (2022), against an average of $1.7 million.
- The sharpest annual moves came in 2022 and 2025: Cash from Investing Activities jumped 283.28% in 2022, then sank 3069.17% in 2025.
- Talphera's Cash from Investing Activities stood at $2.7 million in 2022, then slumped by 237.26% to -$3.7 million in 2023, then surged by 116.43% to $600000.0 in 2024, then soared by 478.33% to $3.5 million in 2025, then slumped by 178.21% to -$2.7 million in 2026.
- Business Quant data shows TLPH's Cash from Investing Activities at -$2.7 million in Q1 2026, $3.5 million in Q4 2025, and -$17.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -491.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -300.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -550.24 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 87.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -51.60 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -135.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -110.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Talphera | 90.25 Mn | 90.25 Mn | - | 1.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.10 Mn |
| Jun 30, 2026 | 1.10 Mn |
| Mar 31, 2026 | -2.71 Mn |
| Mar 31, 2026 | -2.71 Mn |
| Dec 31, 2025 | 3.47 Mn |
| Dec 31, 2025 | 3.47 Mn |
| Sep 30, 2025 | -17.82 Mn |
| Sep 30, 2025 | -17.82 Mn |
| Sep 30, 2024 | 600,000.00 |
| Sep 30, 2024 | 600,000.00 |
| Jun 30, 2024 | 5.91 Mn |
| Jun 30, 2024 | 5.91 Mn |
| Mar 31, 2024 | -2.73 Mn |
| Mar 31, 2024 | -2.73 Mn |
| Dec 31, 2023 | -3.65 Mn |
| Dec 31, 2023 | -3.65 Mn |
| Jun 30, 2023 | 2.72 Mn |
| Jun 30, 2023 | 2.72 Mn |
| Mar 31, 2023 | 400,000.00 |
| Mar 31, 2023 | 400,000.00 |